Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood

Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder and the most common cause of cognitive decline. The alarming epidemiological features of Alzheimer's disease, combined with the high failure rate of candidate drugs tested in the preclinical phase, impose more intense...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourdakou, Marilena M., Fernández-Ginés, Raquel, Cuadrado, Antonio, Spyrou, George M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500459/
https://www.ncbi.nlm.nih.gov/pubmed/37696195
http://dx.doi.org/10.1016/j.redox.2023.102881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500459/
https://www.ncbi.nlm.nih.gov/pubmed/37696195
http://dx.doi.org/10.1016/j.redox.2023.102881

Ejemplares similares